Webinar from the 2015 ASHP MCM is now available to you:
Click here to view: Moving Targets: An Update on Legislation and Standards Aimed at Ensuring the Quality of Pharmaceutical and Compounded Drug Products in the U.S. (3 hours ACPE-Approved CE)
During this webinar, you will learn about different conditions for compounding under sections 503A and 503B of the FDCA. It will discuss the evolving FDA oversight and emerging guidance on topics such as repackaging, and tools for hospitals looking to source from FDA-regulated outsourcing facilities. This webinar will also examine drug traceability law. In addition, this webinar will cover critical developments in USP standards.
Quality standards for large scale compounding
The Pew Charitable Trusts commissioned Clinical IQ to publish a paper, titled Quality Standards for Large Scale Sterile Compounding. The paper chronicles the changes in scope and magnitude of sterile drug compounding from the 1980s to the present day and contrasts the quality systems established for pharmaceutical companies that manufacture drugs with those established to guide traditional pharmacy sterile compounding practice....Read PaperView the CGMP-797 Crosswalk Resource
USP 797 Compliance Map
Use our interactive compliance map to see how each State measures up against USP 797. Includes State Board Contact information, and several checkpoints to consider.View Map
NIH News Release
Clinical IQ, along with Working Buildings, is working with NIH to review their current facilities and processes to ensure patient’s are receiving the highest standard of care at all of NIH’s facilities. Click the article below to read about NIH and Clinical IQ’s efforts.
What Pharmacists Need to Know Ahead of USP <800>
Read coverage of a symposium that was held at the ASHP Midyear Meeting and Exhibition in December of 2014. The faculty included Patricia C. Kienle, M.P.A., B.S.Pharm., FASHP, Thomas H. Connor, Ph.D., and Jeannell Mansur, Pharm.D., FASHP, FSMSO, CJCP. Coverage focus on how pharmacists can start preparing for the new standards in handling hazardous drugs.See More
We have the expertise to guide you through the toughest decisions, and resources to train your staff to be the best in the business.
Call us (973-765-9393) or e-mail us.
We'd love to help.